Keyhole limpet hemocyanin, a novel immune stimulant with promising anticancer activity in Barrett's esophageal adenocarcinoma

American Journal of Surgery

Volumn 186, Issue 5, 2003, Pages 552-555

  McFadden, David W ^a   Riggs, Dale R ^a   Jackson, Barbara J ^a   Vona Davis, Linda ^a  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Barrett's esophagus; Esophageal cancer; Keyhole limpet hemocyanin

Indexed keywords

KEYHOLE LIMPET HEMOCYANIN;

ADENOCARCINOMA; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BARRETT ESOPHAGUS; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ESOPHAGUS CARCINOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0242361291     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2003.08.002     Document Type: Article

References (21)

1. Riggs D.R., Jackson B., Vona-Davis L., McFadden D. In vitro anticancer effects of a novel immunostimulant keyhole limpet hemocyanin . J Surg Res. 108:2002;279-284.
2. Harris J.R., Markl J. Keyhole limpet hemocyanin molecular structure of a potent marine immunoactivator. A review . Eur Urol. 37:(suppl 3):2000;24-33.
3. Tzianabos A.O. Polysaccharide immunomodulators as therapeutic agents structural aspects and biologic function . Clin Microbiol Rev. 13:2000;523-533.
4. Olsson C.A., Chute R., Rao C.N. Immunologic reduction of bladder cancer recurrence rate. J Urol. 111:1974;173-176.
5. Riggs D.R., Tarry W.F., DeHaven J.I., et al. Immunotherapy of murine transitional cell carcinoma of the bladder using alpha and gamma interferon in combination with other forms of immunotherapy. J Urol. 147:1992;212-214.
6. Jurincic-Winkler C.D., Metz K.A., Beuth J., Klippel K.F. Keyhole limpet hemocyanin for carcinoma in situ of the bladder a long-term follow-up study . Eur Urol. 37:(suppl 3):2000;45-49.
7. Jurincic-Winkler CD, von der Kammer H, Beuth J, et al. Antibody response to keyhole limpet hemocyanin (KLH) treatment in patients with superficial bladder carcinoma. Anticancer Res 1996;16:2105-10.
8. Lamm D.L., DeHaven J.I., Riggs D.R. Keyhole limpet hemocyanin immunotherapy of bladder cancer laboratory and clinical studies . Eur Urol. 37:(3):2000;41-44.
9. DeMeester T.R. Barrett's esophagus. Surgery. 113:1993;239-241.
10. Streitz J.M., Ellis F.H., Gibb S.P., et al. Adenocarcinoma in Barrett's esophagus. A clinicopathologic study of 65 cases. Ann Surg. 213:1991;122-125.
11. Williamson W.A., Ellis F.H., Gibb S.P., et al. Effect of antireflux operation on Barrett's mucosa. Ann Thorac Surg. 49:1990;537-541.
12. Devesa S.S., Blot W.J., Fraumeni J.F. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer. 83:1998;2049-2053.
13. Soldes O.S., Kuick R.D., Thompson I.A., et al. Differential expression of Hsp27 in normal oesophagus, Barrett's metaplasia and oesophageal adenocarcinomas. Br J Cancer. 79:1999;595-603.
14. Mosmann T. Rapid colorimetric assay for cellular growth and survival application to proliferation and cytotoxicity assays . J Immunol Meth, 65:1983;55-63.
15. Ludbrook J. Multiple comparison procedures updated. Clin Exp Pharmacol Physiol. 25:1998;1032-1037.
16. Lamm D.L., DeHaven J.I., Riggs D.R., Ebert R.F. Immunotherapy of murine bladder cancer with keyhole limpet hemocyanin (KLH). J Urol. 149:1993;648-652.
17. Thompson C.B. Apoptosis in the pathogenesis and treatment of disease. Science. 267:1995;1456-1462.
18. Martin K., Kirkwood T.B., Potten C.S. Age changes in stem cells of murine small intestinal crypts. Exp Cell Res. 241:1998;316-323.
19. Tsai T.T., Bongiorno P.F., Orringer M.B., Beer D.G. Detection of p53 nuclear protein accumulation in brushings and biopsies of Barrett's esophagus. Cancer Detect Prev. 21:1997;326-331.
20. Souza R.F., Shewmake K., Beer D.G., et al. Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells. Cancer Res. 60:2000;5767-5772.
21. Jemal A., Murray T., Samuels A., et al. Cancer statistics, 2003. CA Cancer J Clin. 53:2003;5-26.